DIETARY SUPPLEMENT REKECEN IMPROVES SAFETY AND EFFICACY OF CHRONIC PROSTATITIS ANTIBACTERIAL THERAPY


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

This randomized comparative study was carried out to estimate efficacy and safety of the natural complex of fermented food fibers and short chain fatty acids (dietary supplement rekicen-RD ®) in antibacterial therapy of 64 patients with chronic infectious prostatitis. 32 patients of the treatment group received 8 week standard antibacterial therapy for chronic prostatitis in combination with dietary supplement rekicen-RD ® and 32 patients of the control group were treated only with antibacterial therapy. Short-term and longterm results were estimated after 8 weeks and 6 months follow-up, respectively. It was found, that addition of dietary supplement rekicen- RD ® to antibacterial therapy resulted in statistically significant improvement of the treatment efficacy. Compared to patients of the control group, patients of the treatment group had more pronounced positive changes of all indicators of treatment efficacy (NIH-CPSI total score, quality of life, echo-structure of prostate, the number of leukocytes in prostatic secretions). Long-term (after 6 months) clinical efficacy of the combination of antibacterial therapy with dietary supplement rekicen-RD ® was 96,9%, bacteriological efficacy after 8 weeks - 87,5%, after 6 months - 81%. Notably, there was 4,5-fold reduction in the rate of antibiotics adverse side effects in the treatment group patients without a single gastro-intestinal side effect.

Full Text

Restricted Access

About the authors

V. F. Kuznetsov

SBEI HPE «Perm State Medical Academy n.a. acad. E.I. Vagner» of the Ministry of Health of the Russian Federation

Email: vk1954@mail.ru
Ph.D. , Prof., Head of Department of Normal Physiology

M. I. Davidov

SBEI HPE «Perm State Medical Academy n.a. acad. E.I. Vagner» of the Ministry of Health of the Russian Federation

Course of Urology and Department of Normal Physiology

A. P. Sokolov

SBEI HPE «Perm State Medical Academy n.a. acad. E.I. Vagner» of the Ministry of Health of the Russian Federation

Course of Urology and Department of Normal Physiology

S. V. Kuznetsov

SBEI HPE «Perm State Medical Academy n.a. acad. E.I. Vagner» of the Ministry of Health of the Russian Federation

Course of Urology and Department of Normal Physiology

References

  1. Степенский А.Б., Попов С.В., Муфагед М.Л. Диагностика и лечение хронического простатита. Consilium Medicum. 2003;5(7):396-401.
  2. Krieger J.N. Classification, epidemiology and implications of chronic prostatitis in North America, Europe and Asia. Minerva Urol. Nephrol. 2004;56 (2) :99-107.
  3. Перепанова Т.С. Современное ведение пациентов с хроническим простатитом. Эффективная фармакотерапия в урологии. 2009;2:2-7.
  4. Ткачук В.Н. Хронический простатит. М.: Медицина, 2006. 112 с.
  5. Bundrick W, Heron S., Ray P. Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis. Urology. 2003;62:537-541.
  6. Fowler I. Antimicrobial therapy for bacterial and nonbacterial prostatitis. Urology. 2002;60(6):24-26.
  7. Naber K.G. Management of bacterial prostatitis. Brit. J. Urol. 2008;3:7-10.
  8. Максимов В.А., Забиров К.И., Мусаков В.Ю., Яровой С.К. Клинико-диагностические критерии и фармакотерапия хронического бактериального простатита. Урология. 2008;5:69-71.
  9. Мальцев В.Н., Шатохин М.Н. Влияние лонгидазы на содержание цитокинов при патологии предстательной железы. Аллергология и иммунология. 2009; 10(2):243.
  10. Теодорович О.В., Шатохин М.Н., Мальцев В.Н., Конопля А.И., Краснов А.В., Локтионов А.Л. Коррекция местных иммунометаболических нарушений при аденоме предстательной железы в сочетании с хроническим простатитом. Урология. 2010;5:22-26.
  11. Kim B.R., Seo H.S., Ku J.M., Kim G.J., Jeon C.Y., Park J.H., Jang B.H., Park S.J., Shin Y.C., Ko S.G. Silibinin inhibits the production of pro-inflammatory cytokines through inhibition of NF-kB signaling pathway in HMC-1 human mast cells. Inflamm. Res. 2013;62(11):941-950.
  12. Шевяков М.А. Коррекция дисбиоза кишечника: современные подходы. Лечащий врач. 2007 ;6:2-7.
  13. Canani R.B., Di Costanzo M., Leone L., Pedata M., Meli R., Calignano A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J. Gastroenterol. 2011;17(12): 1519-1528.
  14. Meares E.M., Stamey T.A. Bacteriological localization patterns in bacterial prostatitis and urethritis. Invest. Urol. 1968;5:492.
  15. Кузнецов В.Ф., Косарева П.В., Негодяева Н.Л., Обернебесо- ва Т.П. Ферментированные пищевые волокна (Рекицен-РД) в реабилитации пациентов с патологией иммунной системы. Аллергология и иммунология. 2009; 10(2):267-268.
  16. Andoh A., Fujiyama Y., Hata K., Araki Y., Takaya H., Shimada M., Bamba T. Counter-regulatory effect of sodium butyrate on tumour necrosis factor-alpha (TNF-alpha)-induced complement C3 and factor B biosynthesis in human intestinal epithelial cells. Clin. Exp. Immunol. 1999;118:23-29.
  17. Hamer H.M. Short chain fatty acids and colonic health. Wageningen: The Top Institute Food and Nutrition, 2009. 168 p.
  18. Karaki S.-H, Kuwahara A. Free fatty acid receptors and their physiological roles in colon. Medicina Wet. 2010;66(3):147-155.
  19. Place R.F., Noonan E.J., Giardina C. HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down- regulation of proteasome subunit expression stabilizes Ikappa B alpha. Biochem. Pharmacol. 2005;70:394-406.
  20. Кузнецов В.Ф. Применение натурального комплекса ферментированных пищевых волокон и метаболитов симбионтного пищеварения в гастроэнтерологической практике Медицинский альманах. 2013;1(25):86-88.
  21. Кузнецов С.В. Продукты симбионтного пищеварения и коррекция соотношения серотонина крови, маркеров повреждения и регенерации гепатоцитов старых крыс при стрессе. Медицинский альманах. 2012;4(23):168-170.
  22. Кузнецов В.Ф., Кулемин Л.М., Уланова Т.С., Землянова М.А., Кузнецов С.В. Клинико-лабораторное обоснование использования ферментированных пищевых волокон при интоксикации, вызванной металлами и ароматическими углеводами. Омский научный вестник. 2010;1 (94):67-69.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Bionika Media